TY - JOUR
T1 - Evaluation of Adverse Events and the Impact on Health-Related Outcomes in Patients Undergoing Surgery for Metastatic Spine Tumors
T2 - Analysis of the Metastatic Tumor Research and Outcomes Network (MTRON) Registry Dataset
AU - Barbanti Brodano, Giovanni
AU - Griffoni, Cristiana
AU - Salamanna, Francesca
AU - Noli, Luigi Emanuele
AU - Monetta, Annalisa
AU - Luzzati, Alessandro
AU - Disch, Alexander C
AU - Lazary, Aron
AU - Barzilai, Ori
AU - Laufer, Ilya
AU - Gokaslan, Ziya L
AU - Fehlings, Michael G
AU - Verlaan, Jorrit-Jan
AU - Chou, Dean
AU - Rhines, Laurence D
AU - Shin, John H
AU - Teixeira, William G J
AU - Sciubba, Daniel M
AU - Bettegowda, Chetan
AU - Charest-Morin, Raphaële
AU - Boriani, Stefano
AU - Goldschlager, Tony
AU - Weber, Michael H
AU - Clarke, Michelle J
AU - O'Toole, John E
AU - Netzer, Cordula
AU - Goodwin, C Rory
AU - Mesfin, Addisu
AU - Mummaneni, Praveen V
AU - Dea, Nicolas
AU - Reynolds, Jeremy J
AU - Sahgal, Arjun
AU - Fisher, Charles G
AU - Gasbarrini, Alessandro
N1 - Publisher Copyright:
© The Author(s) 2025. This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
PY - 2026/1
Y1 - 2026/1
N2 - Study DesignThis study is part of the AO Spine Metastatic Tumor Research and Outcomes Network [MTRON], an international multicenter prospective observational registry including patients with spinal metastases.ObjectivesThis study aims to elucidate the incidence of surgical complications, their risk factors and consequent effects on survival outcomes, hospital length of stay, and overall health-related quality of life (HRQOL) parameters in a large cohort of patients affected by spinal metastases who were surgically treated.MethodsAvailable data from February 2017 to July 2023 were analyzed. The primary outcome of this study was the evaluation of the incidence of intraoperative and postoperative adverse events (AEs). The secondary outcomes included the assessment of risk factors for surgery-related AEs and the impact of AEs on survival, length of hospital stay and quality of life.ResultsAmong the 1267 patients analyzed, 6.9% experienced intraoperative AEs and 19.3% experienced at least 1 postoperative AE. Several factors resulted to be associated to the occurrence of postoperative AEs: age, smoking habit, poor Eastern Cooperative Oncology Group (ECOG) Performance status, previous radiation therapy at the index target, duration of surgery, number of instrumented levels, simultaneous anterior and posterior approach, presence of metastases at other sites, multiple spinal metastases. Postoperative AEs were associated with reduced survival rates, increased hospital length of stay and poorer HRQOL outcomes, particularly in domains such as neurological function and mental health. In general, surgery substantially improves HRQOL across multiple domains, with these benefits persisting over time despite the occurrence of AEs. However, patients with preoperative risk factors, including comorbidities, smoking, neurological impairment, and prior radiation therapy, experienced less improvement.ConclusionsThe negative impact of AEs on overall survival and HRQOL could be associated with the presence of some preoperative parameters of frailty that are detected as risk factors for AEs occurrence. This finding emphasizes the need for personalized preoperative assessments and optimized perioperative care strategies.
AB - Study DesignThis study is part of the AO Spine Metastatic Tumor Research and Outcomes Network [MTRON], an international multicenter prospective observational registry including patients with spinal metastases.ObjectivesThis study aims to elucidate the incidence of surgical complications, their risk factors and consequent effects on survival outcomes, hospital length of stay, and overall health-related quality of life (HRQOL) parameters in a large cohort of patients affected by spinal metastases who were surgically treated.MethodsAvailable data from February 2017 to July 2023 were analyzed. The primary outcome of this study was the evaluation of the incidence of intraoperative and postoperative adverse events (AEs). The secondary outcomes included the assessment of risk factors for surgery-related AEs and the impact of AEs on survival, length of hospital stay and quality of life.ResultsAmong the 1267 patients analyzed, 6.9% experienced intraoperative AEs and 19.3% experienced at least 1 postoperative AE. Several factors resulted to be associated to the occurrence of postoperative AEs: age, smoking habit, poor Eastern Cooperative Oncology Group (ECOG) Performance status, previous radiation therapy at the index target, duration of surgery, number of instrumented levels, simultaneous anterior and posterior approach, presence of metastases at other sites, multiple spinal metastases. Postoperative AEs were associated with reduced survival rates, increased hospital length of stay and poorer HRQOL outcomes, particularly in domains such as neurological function and mental health. In general, surgery substantially improves HRQOL across multiple domains, with these benefits persisting over time despite the occurrence of AEs. However, patients with preoperative risk factors, including comorbidities, smoking, neurological impairment, and prior radiation therapy, experienced less improvement.ConclusionsThe negative impact of AEs on overall survival and HRQOL could be associated with the presence of some preoperative parameters of frailty that are detected as risk factors for AEs occurrence. This finding emphasizes the need for personalized preoperative assessments and optimized perioperative care strategies.
KW - adverse events
KW - complications
KW - length of stay
KW - quality of life
KW - spinal metastases
KW - surgical treatment
KW - survival
UR - https://www.scopus.com/pages/publications/105007765482
U2 - 10.1177/21925682251347247
DO - 10.1177/21925682251347247
M3 - Article
C2 - 40480956
SN - 2192-5682
VL - 16
SP - 410
EP - 433
JO - Global Spine Journal
JF - Global Spine Journal
IS - 1
ER -